Video

Screening Opportunities and Policy Updates in HCV

Author(s):

Parvez Mantry, MD,Mamta Jain, MD, MPH

Parvez Mantry, MD, examines the question of why so many patients with HCV do not undergo therapy. He also discusses policy updates aimed at improving screening and expanding access to treatment.

Related Videos
Christine Frissora, MD | Credit: Weill Cornell
Chari Cohen, DrPH, MPH | Credit: LinkedIn
Zoi Papalamprakopoulou, MD | Credit: Papalamprakopoulou on LinkedIn
Parent Stress Reduces Over Time When Weaning Child Off Tube Feeding with Hide Okuno, MS
Related Content
FDA black and white logo | Credit: US Food and Drug Administration
December 19th 2024

FDA Issues CRL to Glepaglutide for Short Bowel Syndrome, Cites Insufficient Evidence

Abigail Brooks, MA
Innovations in GERD: What Vonoprazan (Voquezna) May Offer Over PPIs, with Adelina Hung, MD
July 18th 2024

Innovations in GERD: What Vonoprazan (Voquezna) May Offer Over PPIs, with Adelina Hung, MD

Abigail Brooks, MA
Houman Ashrafian, MD, PhD | Credit: Sanofi
December 17th 2024

Duvakitug Meets Primary Endpoints in Phase 2b RELIEVE UCCD Study for IBD

Abigail Brooks, MA
Bindu Anand Balani, MD: Eradicating Hepatitis C Virus by 2030
July 28th 2022

Bindu Anand Balani, MD: Eradicating Hepatitis C Virus by 2030

Kenny Walter
FDA logo black and white | Credit: US Food and Drug Administration
December 12th 2024

Tobevibart, Elebsiran Receive FDA Breakthrough Therapy Designation for Chronic HDV

Abigail Brooks, MA
Insulin Resistance Amplifies Risk of Colorectal Cancer Development | Image Credit: ResearchGate
December 12th 2024

Insulin Resistance Amplifies Risk of Colorectal Cancer Development

Connor Iapoce
© 2024 MJH Life Sciences

All rights reserved.